Standout Papers

Local Ablative Therapy of Oligoprogressive Disease Prolongs Disease Control by Tyrosine Kinase Inh... 2012 2026 2016 2021 489
  1. Local Ablative Therapy of Oligoprogressive Disease Prolongs Disease Control by Tyrosine Kinase Inhibitors in Oncogene-Addicted Non–Small-Cell Lung Cancer (2012)
    Andrew Weickhardt, Benjamin Scheier et al. Journal of Thoracic Oncology

Immediate Impact

9 from Science/Nature 66 standout
Sub-graph 1 of 20

Citing Papers

Spatiotemporally resolved colorectal oncogenesis in mini-colons ex vivo
2024 StandoutNature
Fluorescent Probes for Disease Diagnosis
2024 Standout
9 intermediate papers

Works of Gregory N. Gan being referenced

Local Ablative Therapy of Oligoprogressive Disease Prolongs Disease Control by Tyrosine Kinase Inhibitors in Oncogene-Addicted Non–Small-Cell Lung Cancer
2012 Standout
Continuation of EGFR/ALK inhibition after local therapy of oligoprogressive disease in EGFR mutant (Mt) and ALK+ non-small cell lung cancer (NSCLC).
2012
and 2 more

Author Peers

Author Last Decade Papers Cites
Gregory N. Gan 913 783 102 564 57 1.8k
Philip P. Connell 702 761 44 768 68 2.3k
Baukelien van Triest 753 1115 22 626 78 2.2k
Margaret M. Kozak 312 741 77 617 48 1.5k
J. Doyen 637 690 45 506 101 1.8k
Charalambos Kouroussis 732 1025 88 261 49 1.5k
Yee‐Min Jen 521 362 442 517 69 1.9k
Suzanne Russo 611 867 39 650 71 1.7k
W. Jeffrey Petty 1014 1184 83 865 108 2.5k
Skye Hongiun Cheng 412 548 410 261 32 1.6k
Henrik Roed 508 738 22 305 53 1.7k

All Works

Loading papers...

Rankless by CCL
2026